What’s new

• Methodhub partnered with Datafoundry for AI-driven pharmacovigilance solutions.
• The collaboration targets global pharma, biotech, and life sciences companies.
• No financial terms, contract values, or revenue guidance disclosed.

Why it matters

For a ₹157 cr market cap firm, entering a regulated niche like pharmacovigilance signals a strategic bet on higher-margin recurring revenue. But without a contract or revenue commitment, the market has little to price today.

What we’re watching

• Any client wins or contract values tied to the partnership.
• Whether this translates to revenue diversification in coming quarters.
• Next earnings call for updates on partnership progress.

The full read

Fresh from doubling revenue to ₹334.56 cr via US acquisitions, Methodhub Software is pushing into pharma-tech. The nano-cap IT firm has partnered with Datafoundry, an AI/ML SaaS provider, to offer pharmacovigilance automation to global life sciences companies. Methodhub will bring its regulatory compliance and PV operations; Datafoundry contributes Safety AI, Signal AI, and Literature Monitor platforms to automate case processing, adverse event reporting, and signal detection. No numbers, no client, no revenue commitment. The press release alone won't move the needle. But the direction is clear: Methodhub is trying to carve out a specialized vertical beyond generic IT services. What changes from here is execution. Without a single named client or revenue commitment, this is a bet, not a deal.

Primary source: BSE · NSE

What’s new

• Board approved acquiring Venusgeo Solutions, a Mexican IT services company with nil revenue for three years.
• The acquisition will be made through MethodHub's US subsidiary. The cost is undisclosed.
• Board also approved incorporating a Costa Rica subsidiary with a USD 10,000 investment.

Why it matters

For a nano-cap already executing multiple US acquisitions, two more undetermined-cost moves in Latin America are incremental. The target is pre-revenue, making strategic value the only obvious rationale. The deal adds pins to the map without moving the financial needle.

What we’re watching

• Disclosure of the acquisition price for Venusgeo.
• How MethodHub plans to generate revenue from a target with a three-year sales blank.
• Whether these Latin American entities become active or remain shells.

The full read

MethodHub is buying Venusgeo Solutions, a Mexican IT services shop with nil revenue for three straight years. The price is undisclosed. Separately, the board created a Costa Rica subsidiary for USD 10,000. For a nano-cap already executing multiple US buys, two more undetermined-cost moves in Latin America are the definition of incremental. Hardly. The target is pre-revenue, so the rationale has to be strategic, not financial. The open question is whether these entities will ever generate sales.

Primary source: BSE · NSE

What’s new

• Consolidated revenue reached ₹334.56 cr, up from ₹136.28 cr a year earlier.
• Net profit rose to ₹31.84 cr from ₹11.50 cr, aided by overseas integration.
• Standalone revenue grew 7% to ₹63.96 cr, with standalone profit up 39% to ₹9.09 cr.

Why it matters

Methodhub is using acquisitions to scale its footprint, but the gap between consolidated and standalone growth shows how much the firm relies on its US units. The real test is whether these new assets can maintain their margins without the initial integration tailwinds. It is a classic inorganic growth story for a nano-cap firm.

What we’re watching

• Whether the company can sustain organic growth in its standalone business.
• Client retention rates for the newly acquired Leo Technology and SEW-Tech.
• Margin stability as the company continues its AI and cloud investments.

The full read

Methodhub Software closed FY26 with consolidated revenue of ₹334.56 crore, a 145.5% increase over the previous year. The surge is the result of inorganic expansion, specifically the integration of US-based Leo Technology Ventures and SEW-Tech.

Profitability followed suit.

Consolidated net profit rose to ₹31.84 crore from ₹11.50 crore, but the standalone business tells a more tempered story. Standalone revenue grew just 7% to ₹63.96 crore, suggesting that the company's domestic operations are not keeping pace with its overseas acquisitions. Management is now pointing to HIPAA certification and new wins in BFSI and healthcare as the next growth levers. The company is betting heavily on AI and cloud services to justify the acquisition costs. For a nano-cap firm, this is a rapid transformation of the balance sheet. The open question is whether the standalone business can eventually match the momentum of the acquired units.

Primary source: BSE · NSE

What’s new

• Consolidated revenue more than doubled to ₹33.29 cr.
• Net profit rose to ₹3.18 cr from ₹1.15 cr.
• Standalone revenue grew 7.5% to ₹6.30 cr.

Why it matters

Methodhub's growth is entirely inorganic. The delta between the consolidated and standalone performance shows that the company's core business is growing at a much slower pace than its acquisition-led expansion.

What we’re watching

• Whether the acquired US entities can sustain their contribution in FY27.
• Integration costs associated with the four new US subsidiaries.
• Standalone growth rates in the coming quarters.

The full read

Methodhub Software ended FY26 with consolidated revenue of ₹33.29 crore, more than double the ₹13.51 crore reported in the prior year. This expansion is the direct result of four US acquisitions completed during the second half of the year, including SEW-Tech Inc. and Leo Technology Ventures Inc. Net profit attributable to the parent followed suit, rising to ₹3.18 crore from ₹1.15 crore. The standalone business, however, tells a different story. Revenue there grew by a modest 7.5% to ₹6.30 crore, while net profit increased 44% to ₹0.91 crore. The company also finalized routine governance updates, appointing Anil Nair & Associates as internal auditors and regularizing two independent directors. The core takeaway is clear: Methodhub's scale is now tied to its ability to integrate and maintain its new US assets, as the standalone business remains a small fraction of the total group performance.

Primary source: BSE · NSE

What’s new

• Consolidated revenue more than doubled to ₹33.29 crore.
• Net profit rose to ₹3.18 crore from ₹1.15 crore.
• Standalone revenue growth remained modest at 7.5%.

Why it matters

Methodhub is a different company than it was a year ago due to its inorganic expansion. The contrast between the consolidated surge and the muted standalone performance shows that growth is currently dependent on its US acquisitions.

What we’re watching

• Whether the acquired entities maintain their contribution in FY27.
• Integration costs that may weigh on future margins.
• Any further M&A activity to sustain the current growth trajectory.

The full read

Methodhub Software is scaling through acquisition. The firm reported FY26 consolidated revenue of ₹33.29 crore, more than double the ₹13.51 crore recorded in FY25. This surge follows the integration of four US-based entities, including SEW-Tech Inc. and Leo Technology Ventures Inc. Consolidated net profit climbed to ₹3.18 crore from ₹1.15 crore. Beneath the consolidated figures, the core standalone business remains small. Standalone revenue grew 7.5% to ₹6.30 crore, while standalone net profit rose 43% to ₹0.91 crore. The board appointed Anil Nair & Associates as internal auditors and added two independent directors. The company used M&A to shift its scale, and the reliance on these new US entities for growth is now the defining feature of the business.

Primary source: BSE · NSE